Skip to main content
Clinical Trials/NCT01828853
NCT01828853UnknownNot Applicable

Maternal and Neonatal Outcomes After Membrane Sweeping

Hadassah Medical Organization1 site in 1 country1,200 target enrollmentStarted: April 2013Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
1,200
Locations
1
Primary Endpoint
Neonatal sepsis

Study Overview

Brief Summary

This study aim to estimate maternal and neonatal outcomes after membrane sweeping in different group of patients.

Detailed Description

Sweeping of the membranes is a simple technique usually performed during vaginal examination, in order to initiate labour by increasing local production of prostaglandins.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
17 Years to 45 Years (Child, Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Women with a singleton pregnancy and confirmed cephalic presentation at or after 37 weeks of gestation who are candidate for vaginal delivery were eligible for the study

Exclusion Criteria

  • Women with a multiple pregnancy, nonreassuring cardiotocogram, meconium stained amniotic fluid, major fetal anomalies, HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, or severe preeclampsia and signs of intrauterine infections were not eligible.
  • women who are not candidates for vaginal delivery: placenta previa, breech presentation, planned repeat cesarean.

Outcomes

Primary Outcomes

Neonatal sepsis

Time Frame: Neonates will be followed for the duration of hospital stay, an expected average of 2-3 days

Secondary Outcomes

  • Neonatal infection(Neonates will be followed for the duration of hospital stay, an expected average of 2-3 days)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Maternal and Neonatal Outcomes After... | Clinical Trial